Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.7 USD | -1.52% | -5.23% | -18.52% |
06:31pm | Bristol-Myers Squibb Unveils Positive Data for KarXT in Schizophrenia Treatment | MT |
May. 22 | Bristol Myers, Sanofi liability in Hawaii Plavix case grows to $916 million | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.52% | 85.83B | |
+40.46% | 723B | |
+34.28% | 595B | |
-3.84% | 369B | |
+20.53% | 332B | |
+3.07% | 282B | |
+17.02% | 244B | |
+9.31% | 208B | |
-5.07% | 205B | |
+0.28% | 168B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Bristol Myers Squibb : Opdivo Meets Phase 3 Lung Cancer Study Goals